Spinal cord stimulation for the treatment of painful diabetic neuropathy and risk of major adverse cardiovascular events, mortality, amputation, infection and suicide: a retrospective cohort study
{{output}}
Background: Spinal cord stimulation (SCS) has recently been approved by the US Food and Drug Administration (FDA) for the treatment of refractory painful diabetic neuropathy (PDN), although the current evidence for efficacy is li... ...
